Literature DB >> 2836660

Metastatic extramammary Paget's disease: dramatic response to combined modality treatment.

L Balducci1, M Athar, G F Smith, T Khansur, D McKenzie, E D Crawford.   

Abstract

A case of extramammary Paget's disease is reported. The distinguishing features of the case are: (1) localization of the primary lesion to the scrotum, (2) development of metastases in the absence of a recognizable underlying carcinoma, and (3) response of the systemic disease to a combination of radiation therapy and chemotherapy. The histogenesis, clinical behavior, and treatment of extramammary Paget's disease are reviewed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2836660     DOI: 10.1002/jso.2930380111

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  5 in total

1.  Management of penoscrotal extramammary Paget disease: case series and review of the literature.

Authors:  P Moretto; V J Nair; S El Hallani; S Malone; E Belanger; C Morash; C M Canil
Journal:  Curr Oncol       Date:  2013-08       Impact factor: 3.677

2.  Retrospective analysis of perianal Paget's disease with underlying anorectal carcinoma.

Authors:  Peng Lian; Wei-Lie Gu; Zhen Zhang; Guo-Xiang Cai; Ming-He Wang; Ye Xu; Wei-Qi Sheng; San-Jun Cai
Journal:  World J Gastroenterol       Date:  2010-06-21       Impact factor: 5.742

3.  Treatment of metastatic extramammary Paget's disease associated with adnexal adenocarcinoma, with anti-HER2 drugs based on genomic alteration ERBB2 S310F.

Authors:  Olga Vornicova; Dov Hershkovitz; Tamar Yablonski-Peretz; Ofer Ben-Itzhak; Zohar Keidar; Gil Bar-Sela
Journal:  Oncologist       Date:  2014-08-01

4.  Mayo Clinic Cancer Center Experience of Metastatic Extramammary Paget Disease 1998-2012.

Authors:  Leslie Padrnos; Nina Karlin; Thorvardur R Halfdanarson
Journal:  Rare Tumors       Date:  2016-11-17

5.  Response to 5-fluorouracil in metastatic extramammary Paget disease of the scrotum presenting as pancytopenia and back pain.

Authors:  K M Beleznay; M A Levesque; S Gill
Journal:  Curr Oncol       Date:  2009-09       Impact factor: 3.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.